Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 3Brain Neoplasms 3Carcinoma, Hepatocellular 2Prostatic Neoplasms 1Ovarian Neoplasms 1Neuroendocrine Tumors 1Leiomyoma 1Glioma 1Fibroadenoma 1Colorectal Neoplasms 1Carcinoma, Intraductal, Noninfiltrating 1Breast Diseases 1

Interventions

ulipristal acetate 20Uterine Myomectomy 19telapristone acetate 18vilaprisan 12relugolix 12Leuprolide 11Uterine Artery Embolization 10estradiol, norethindrone drug combination 9asoprisnil 9Estradiol 8elagolix 7Tranexamic Acid 7Mifepristone 7Bupivacaine 7ulipristal 6Norethindrone Acetate 6Hysterectomy 6Saline Solution 5linzagolix 4epigallocatechin gallate 4Sodium Chloride 4Misoprostol 4Letrozole 4Vitamin B 6 3Tablets 3Surveys and Questionnaires 3Sugars 3Radiofrequency Ablation 3Lidocaine 3Hysteroscopy 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Leiomyoma × gadoterate meglumine × Clear all
NCT01514617 2024-07-10

Diffusion -and Perfusion Weighted MRI for Response Prediction of Symptomatic Leiomyomas Following Uterine Artery Embolization

Universitaire Ziekenhuizen KU Leuven

Phase NA Active not recruiting
100 enrolled

Leiomyoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡